TMS therapy for Fort Lauderdale — FDA-cleared TRD care, 40 minutes from home.

RECO Health's Delray Beach campus sits 26 miles — roughly 40 minutes on I-95 — from Las Olas and Victoria Park, close enough for daily rTMS sessions without relocation and far enough to separate treatment from the routines that fed the depression. In-house psychiatry manages medication, prior authorization, and the pivot to ketamine or iTBS when standard 10 Hz rTMS is not the right fit. The full 36-session FDA-cleared protocol is delivered on-site by the same team, with response and remission tracked by PHQ-9 at every weekly checkpoint.

From Las Olas or Victoria Park, RECO Health’s Delray Beach campus is a 40-minute drive north on I-95 — 26 miles that separate daily treatment from the routines and relationships tied to an active depressive episode. For Fort Lauderdale adults whose major depression has not responded to two or more antidepressant trials, transcranial magnetic stimulation offers an FDA-cleared, non-pharmacologic path that fits around work and family without the sedation, weight gain, or sexual side effects of another medication swap. RECO Health delivers the full 36-session repetitive TMS protocol on the same campus that houses in-house psychiatry, medical detox, and ketamine services — so the treatment plan can adjust in either direction without a referral out.

Who is a candidate for rTMS

The insurance-covered indication for rTMS is major depressive disorder — single or recurrent — with documented failure of at least two adequate antidepressant trials. “Adequate” carries specific meaning: therapeutic dose, minimum six-to-eight-week duration, and confirmed adherence. A patient who took sertraline 50 mg for three weeks and stopped does not meet criteria; a patient who reached sertraline 150 mg for eight weeks and then failed a second SSRI or SNRI does. RECO Health’s psychiatry team reconstructs the medication history line by line — agent, dose, duration, response, side effects — and assembles the documentation payers require before authorization is attempted.

Clinical candidacy runs parallel to insurance candidacy but is not identical. Absolute contraindications include ferromagnetic implants near the head (cochlear implants, deep brain stimulators, aneurysm clips). Relative contraindications include a personal or family history of seizures, active untreated substance use, and pregnancy on certain protocols. Bipolar depression is treatable with rTMS but requires mood stabilization on lithium, quetiapine, or lamotrigine first to reduce the risk of switch to mania. Untreated OCD comorbidity may direct the case toward deep TMS on the BrainsWay platform rather than figure-8 coil rTMS. Every candidate completes a PHQ-9 and GAD-7 at intake, and, when clinically indicated, a YBOCS or ASRS to screen comorbidities that would change the protocol.

The 36-session protocol and what it actually looks like

Session one is motor threshold mapping. The technician places the coil over the left motor cortex and steps intensity upward until stimulation reliably evokes a visible thumb twitch in five of ten pulses. That intensity — the resting motor threshold — becomes the reference point; treatment is delivered at 120% of it, over the left dorsolateral prefrontal cortex at coordinates derived from the Beam F3 method or a neuronavigated MRI. The standard depression protocol delivers 3,000 pulses per session at 10 Hz in four-second trains with 26-second inter-train intervals.

Sessions two through thirty run Monday through Friday for six consecutive weeks, roughly 20 to 40 minutes in the chair depending on protocol. Clients remain awake, sit upright, and can read or listen to music during treatment. There is no sedation, no IV, no post-treatment restriction — patients drive themselves back to Fort Lauderdale, return to work the same afternoon, and repeat the process the next morning. The most common adverse effects are scalp discomfort at the stimulation site and mild transient headache in the first week; both typically resolve as tissue tolerance builds.

The final six sessions form the taper: three sessions the seventh week, two the eighth, one the ninth. The taper matters. Payers reimburse it because the durability evidence rests on completing all 36 sessions, and premature discontinuation at session 30 correlates with earlier relapse.

Response, remission, and the second-course question

Published response rates for rTMS in treatment-resistant depression range from 40 to 60 percent, with remission rates between 25 and 40 percent depending on the definition applied and the population studied. Response — a 50 percent reduction in PHQ-9 or Hamilton Depression Rating Scale — typically emerges between sessions 15 and 25. Some patients notice sleep and energy shifts before mood shifts; some describe a lifting of the “gray filter” they had stopped naming. Continued gains through the taper are the norm rather than the exception.

Non-responders at session 20 to 25 are not written off. RECO Health’s psychiatrists re-evaluate coil position (the DLPFC target is small and easy to miss with F3-only localization), re-examine sleep and medication, and consider a switch to intermittent theta burst stimulation for the remaining sessions. Some cases warrant a pivot to the ketamine pathway — IV racemic ketamine or intranasal esketamine — particularly when suicidality is the driving concern. Responders who later relapse are candidates for a second full course, typically 12 to 18 months after the first, and payer authorization for a second course is standard practice with documented prior response.

iTBS and the shorter-session option

Intermittent Theta Burst Stimulation is an FDA-cleared alternative rTMS protocol that delivers equivalent efficacy in a three-minute session. iTBS uses 50 Hz triplet bursts repeated at 5 Hz, delivering 600 pulses in roughly 190 seconds rather than 3,000 pulses across 37.5 minutes. The THREE-D non-inferiority trial (Blumberger et al., Lancet 2018) established equivalence to standard 10 Hz protocols for major depression, and iTBS is now the workhorse protocol at many sites for scheduling reasons alone.

For Fort Lauderdale clients whose workday cannot absorb a 45-minute treatment window plus a 40-minute drive each way, iTBS turns the daily commitment into something closer to a lunch break. Not every commercial plan reimburses iTBS at parity with conventional rTMS, and a small number still require the longer protocol as first-line. RECO Health’s admissions team confirms coverage in advance and matches the protocol to what the patient’s plan will authorize.

What to expect on your first visit

Fort Lauderdale clients begin with a psychiatric evaluation at RECO Health’s Delray Beach campus — 60 to 90 minutes with the treating psychiatrist covering symptom history, medication history, medical comorbidities, and treatment goals. The PHQ-9 and GAD-7 are administered at this visit and repeated weekly through treatment. Prior authorization documentation is assembled at the same appointment; approval typically returns within five to seven business days.

The motor threshold mapping visit follows once authorization is granted. Mapping runs 45 to 60 minutes; treatment sessions themselves begin the next business day. Clients receive a written schedule of all 36 sessions, direct contact for the treatment coordinator, and clear expectations about what constitutes a missed session versus a rescheduled one. For adults integrating TMS therapy with ongoing psychotherapy — CBT for depression, ACT for values-based behavioral activation, or trauma-focused EMDR — the psychiatry team coordinates with the outside clinician so the two treatments reinforce rather than compete.

Insurance and admissions from Fort Lauderdale

RECO Health’s admissions team verifies benefits with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans and completes the prior authorization submission on the client’s behalf. Most commercial plans cover the full 36-session course once two adequate antidepressant trials are documented; a subset require a third trial or documented augmentation failure with aripiprazole, quetiapine, or lithium before authorizing. Copays and coinsurance vary by plan and deductible status, and admissions quotes an estimated out-of-pocket cost before treatment begins.

The 26-mile drive from Las Olas, Victoria Park, Coral Ridge, Rio Vista, or Wilton Manors runs 35 to 45 minutes on I-95 outside peak hours. Morning appointments before 8:30 a.m. and midday windows between 10 a.m. and 2 p.m. avoid the worst southbound rush-hour traffic on the return leg. For clients whose depression has made the daily drive itself a barrier, RECO Health can arrange short-term housing near the Delray Beach campus for the intensive six-week phase.

Serving residents of: Las Olas, Victoria Park, Coral Ridge, Rio Vista, Wilton Manors.